Schedule: PHA 6934, Seminar in Medicinal Chemistry

Tuesday, 9:00 am – 10:00 am in C1-011. *The Oct 15th seminar will be in LG-101A*

Spring 2024 Seminar Schedule

Date Presenter Seminar title
27-Aug Cindy Mercado EHS Lab Safety Meeting
3-Sep Dr. Lina Cui & Dr. Xingui Liu Annual meeting with graduate students & Course Introduction
10-Sep Emma Ellis Neuroprotective azaphilones from a deep-sea derived fungus Penicillium sp. SCSIO41030
10-Sep Meng-Lung Hsieh Discovery of a Novel Bifunctional Steroid Analog, YXG-158, as an Androgen Receptor Degrader and CYP17A1 Inhibitor for the Treatment of Enzalutamide-Resistant Prostate Cancer
17- Sep Kuntala Dey Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast Cancer
17-Sep Yujia Jiang Chemoenzymatic Approaches to Izidine Alkaloids: An Efficient Total Synthesis of (+)-Absouline and Laburnamine
24- Sep Allison C Lynch Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1
1-Oct Cassandra C Farley Research ethic seminar
8-Oct Zhihang Shen Discovery of PRMT5 Inhibitors
15-Oct Peter A Ramdhan Accurate structure prediction of biomolecular interactions with AlphaFold 3
22-Oct Christian Barnard Synthesis, Optimization, and Structure−Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs)
29-Oct Chi-Yuan Liu Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
5-Nov Hsin-Ying Tsai Elucidation of genes enhancing natural product biosynthesis through co-evolution analysis
12-Nov Yuzhao Zhang Design principles for cyclin K molecular glue degraders
19-Nov Seif A Abouheif WLB-87848, a Selective σ1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity
26-Nov Vanisa Petriti Stereoselective amino acid synthesis by photobiocatalytic oxidative coupling
3-Dec Yifan Wang Orpinolide disrupts a leukemic dependency on cholesterol transport by inhibiting OSBP

Table Caption

–– ––
–– ––
–– ––
–– ––